ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) AND EXECUTIVE FUNCTION DEVELOPMENT IN SCHOOL-AGE CHILDREN

ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) AND EXECUTIVE FUNCTION DEVELOPMENT IN SCHOOL-AGE CHILDREN

Authors

  • Mamadaliyev Boburjon Odiljon o‘g‘li 4th-year undergraduate student in Pediatrics, Group 222, Central Asian Medical University e-mail: boburjonmamadaliyev038@gmail.com

Keywords:

A systematic review was conducted to synthesize evidence on EF development in school-age children (6–12 years) with ADHD.

Abstract

 Background

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition of childhood and a major driver of academic underachievement and psychosocial difficulties. Executive functions (EF)—a family of higher-order cognitive control processes—are central to adaptive learning and behavior in school-age children. Despite decades of research, controversy persists regarding the specificity of EF deficits in ADHD, their developmental stability, and the degree to which treatment modifies EF trajectories.

References

Ayano G, Yohannes Z, Abraha M, et al. Global prevalence of attention deficit hyperactivity disorder: An umbrella review of meta-analyses. Psychiatry Res, 2023, (Volume(Issue)):Pages.

Danielson ML, Bitsko RH, Ghandour RM, et al. ADHD prevalence among U.S. children and adolescents: updated national estimates. J Clin Child Adolesc Psychol, 2024, (Volume(Issue)):Pages.

Koutsoklenis A, Honkasilta J. ADHD in the DSM-5-TR: What has changed and what has not. Front Psychiatry, 2023, 13:1064141.

National Academies of Sciences, Engineering, and Medicine. DSM-IV to DSM-5 ADHD diagnostic criteria summary table. NCBI Bookshelf, (Year).

Kofler MJ, Sarver DE, et al. Working memory and inhibitory control mechanisms in children with ADHD: experimental manipulation of cognitive demands. Front Psychiatry, 2024, (Volume(Issue)):Pages.

Hai T, Banaschewski T, et al. Impact of stimulant medication on behavior and executive function in children with ADHD. (Journal), 2022, (Volume(Issue)):Pages.

Vertessen K, et al. Dose-dependent effects of ADHD medication on neurocognitive functions: meta-analysis. J Am Acad Child Adolesc Psychiatry, 2022, (Volume(Issue)):Pages.

Miklós M, et al. Executive function and attention performance in children with ADHD: medicated vs treatment-naïve comparisons. Int J Environ Res Public Health, 2019, 16(20):3822.

Bellato A, et al. Effects of ADHD medication on quality of life: systematic review and meta-analysis of RCTs. J Am Acad Child Adolesc Psychiatry, 2025, (Volume(Issue)):Pages.

Martin AF, et al. The changing prevalence of ADHD: systematic review of post-2020 studies. J Affect Disord, 2025, (Volume(Issue)):Pages.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: APA Publishing, 2022.

Barkley RA. Executive functions: what they are, how they work, and why they evolved. (Book/Monograph), (Year), (Publisher).

Miyake A, Friedman NP. The nature and organization of executive functions: a latent variable analysis. Psychol Rev, 2000, 107(1):49–100.

Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of ADHD: a meta-analytic review. Biol Psychiatry, 2005, 57(11):1336–1346.

Sonuga-Barke EJS, et al. Cognitive models of ADHD and developmental pathways: implications for intervention. (Journal), (Year), (Volume(Issue)):Pages.

Pelham WE, Fabiano GA. Evidence-based psychosocial treatments for ADHD. J Clin Child Adolesc Psychol, 2008, 37(1):184–214.

Downloads

Published

2026-02-01

Issue

Section

##section.default.title##
Loading...